Key Takeaways for Improving CKD Diagnosis and Treatment in Patients With Type 2 Diabetes

Author(s):

Rajiv Agarwal, MD,Mark A. Meeker, DO, FACP, CPE

Key Takeaways

Identifying at-risk patients for CKD in Type 2 Diabetes involves assessing hypertension, family history, and blood glucose levels.
Screening tests for CKD include eGFR and UACR, essential for early detection in diabetic patients.
Early CKD detection allows timely intervention, slowing disease progression and reducing cardiovascular risks.
CKD is a significant risk factor for heart failure, highlighting the importance of early detection for cardiovascular risk management.

Panelists discuss the key takeaways for improving chronic kidney disease (CKD) diagnosis and treatment in patients with type 2 diabetes, emphasizing how to effectively sequence treatment options based on patient types to address cardiovascular and renal risks in both early and advanced stages of the disease.

In closing, what are the key takeaways for improving CKD diagnosis and treatment in patients with type 2 diabetes?
1. Now that we have many options in CKD, how should we think about sequencing these products in different patient types, for instance, to address CV and renal risk, in patients with earlier, less advanced disease as well those with later, advanced stages?